Your browser doesn't support javascript.
loading
Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases?
Genecand, Léon; Lador, Frédéric; Montani, David; Perneger, Thomas.
Afiliación
  • Genecand L; Department of Medicine, Division of Pneumology, University Hospitals of Geneva, Geneva, Switzerland. Electronic address: leon.genecand@hug.ch.
  • Lador F; Department of Medicine, Division of Pneumology, University Hospitals of Geneva, Geneva, Switzerland.
  • Montani D; Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Centre, INSERM UMR_S 999, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
  • Perneger T; Division of Clinical Epidemiology, Department of Health and Community Medicine, University of Geneva & University Hospitals of Geneva, Geneva, Switzerland.
Chest ; 165(5): e161, 2024 May.
Article en En | MEDLINE | ID: mdl-38724160
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Epoprostenol / Enfermedades Pulmonares Intersticiales / Hipertensión Pulmonar / Antihipertensivos Límite: Humans Idioma: En Revista: Chest Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Epoprostenol / Enfermedades Pulmonares Intersticiales / Hipertensión Pulmonar / Antihipertensivos Límite: Humans Idioma: En Revista: Chest Año: 2024 Tipo del documento: Article